- Report
- October 2023
- 133 Pages
Global
From €3059EUR$3,400USD£2,617GBP
€3823EUR$4,250USD£3,272GBP
- Report
- June 2023
- 113 Pages
Global
From €3203EUR$3,560USD£2,740GBP
€4003EUR$4,450USD£3,425GBP
- Report
- December 2022
- 142 Pages
Global
From €3203EUR$3,560USD£2,740GBP
€4003EUR$4,450USD£3,425GBP
- Report
- August 2022
- 140 Pages
Global
From €3059EUR$3,400USD£2,617GBP
€3823EUR$4,250USD£3,272GBP
- Report
- April 2022
- 102 Pages
Global
From €3203EUR$3,560USD£2,740GBP
€4003EUR$4,450USD£3,425GBP
- Report
- September 2020
- 132 Pages
Global
From €3203EUR$3,560USD£2,740GBP
€4003EUR$4,450USD£3,425GBP
- Report
- April 2018
- 80 Pages
Global
From €2375EUR$2,640USD£2,032GBP
€2969EUR$3,300USD£2,540GBP
- Report
- May 2024
- 200 Pages
Global
From €3733EUR$4,150USD£3,195GBP
- Report
- March 2024
- 200 Pages
Global
From €3733EUR$4,150USD£3,195GBP
- Report
- June 2025
United Kingdom
From €1885EUR$2,095USD£1,613GBP
€3590EUR$3,990USD£3,071GBP
- Report
- February 2025
- 29 Pages
Canada
From €4494EUR$4,995USD£3,845GBP
- Report
- February 2025
- 29 Pages
Australia
From €4494EUR$4,995USD£3,845GBP
- Report
- February 2025
- 31 Pages
India
From €4494EUR$4,995USD£3,845GBP
- Report
- February 2025
- 29 Pages
Germany
From €4494EUR$4,995USD£3,845GBP
- Report
- May 2024
- 72 Pages
Global
From €3144EUR$3,495USD£2,690GBP
- Report
- May 2024
- 64 Pages
Global
From €8992EUR$9,995USD£7,694GBP
- Report
- December 2023
- 62 Pages
Global
From €8992EUR$9,995USD£7,694GBP
- Report
- December 2023
- 67 Pages
Global
From €8992EUR$9,995USD£7,694GBP
- Report
- December 2023
- 59 Pages
Global
From €8992EUR$9,995USD£7,694GBP
- Report
- August 2023
- 47 Pages
Global
From €3594EUR$3,995USD£3,075GBP

The Immune Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat immune system disorders. These drugs are used to treat a variety of conditions, including allergies, asthma, autoimmune diseases, and cancer. Immune Disorders Drugs are designed to target specific parts of the immune system, such as cytokines, antibodies, and T-cells, to reduce inflammation and improve the body's ability to fight off infection.
The Immune Disorders Drugs market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are constantly researching and developing new drugs to treat immune system disorders, as well as improving existing treatments. Show Less Read more